Skip to main content

AntAfu's New DeepSearch Tool Gives Doctors an AI-Powered Edge

AntAfu Empowers Doctors With AI-Driven Research Tool

Medical professionals just got a powerful new ally in their daily work. AntAfu's latest PC upgrade introduces DeepSearch, an intelligent search function that's being called China's answer to 'Open Evidence'. Available at no cost to doctors, students, and frontline healthcare workers, this tool promises to transform how medical research gets done.

Image

Smarter Searching for Busy Practitioners

The upgraded platform combines two key features:

  • Health consultation capabilities
  • The new DeepSearch function

Together they serve as an AI assistant that can dramatically cut down the hours doctors spend combing through journals and guidelines. "Time is precious in medicine," explains Dr. Li Wen, an early tester. "Having relevant research at your fingertips changes everything."

Curated Knowledge at Scale

What makes DeepSearch stand out? The team has organized 36 million medical references by evidence quality, blending international standards with China-specific guidelines from groups like the Chinese Medical Association. This dual focus ensures recommendations fit local practice needs while maintaining global rigor.

The database pulls from:

  • Peer-reviewed international journals
  • Latest specialty guidelines
  • Chinese clinical consensus reports
  • Continuously updated treatment protocols

From Research to Bedside Decisions

Beyond simple searches, DeepSearch helps doctors:

  1. Quickly surface cutting-edge treatments
  2. Organize literature automatically
  3. Build evidence-based care plans
  4. Trace sources with annotation tools
  5. Filter results by evidence strength

"Complex cases used to mean nights reviewing papers," shares pediatrician Dr. Chen. "Now I can compare global approaches during rounds."

Completing the Ecosystem

The PC upgrade marks AntAfu's latest move in serving both consumers and professionals:

  • Patient side: Their app fields over 10 million daily health questions
  • Doctor side: 1,000+ physicians use AI avatars to extend their availability

The company's proprietary healthcare AI model powers both experiences seamlessly.

The timing couldn't be better as China's healthcare system faces growing demands."We're giving clinicians superpowers," says AntAfu CEO Zhang Wei. "Better tools mean better care for everyone."

Key Points:

  • Free professional tool: DeepSearch available to medical workers nationwide
  • Massive knowledge base: 36 million vetted references at doctors' fingertips
  • Local + global: Blends international standards with Chinese practice needs
  • Time savings: AI organizes research so clinicians can focus on patients

Enjoyed this article?

Subscribe to our newsletter for the latest AI news, product reviews, and project recommendations delivered to your inbox weekly.

Weekly digestFree foreverUnsubscribe anytime

Related Articles

AI breakthrough spots hidden fatty liver risks in routine scans
News

AI breakthrough spots hidden fatty liver risks in routine scans

Alibaba's DAMO Academy has unveiled an AI model that detects fatty liver disease from standard CT scans with remarkable accuracy. The MAOSS system outperforms doctors in spotting early signs of liver damage, potentially preventing thousands of cases from progressing to cirrhosis. What makes this innovation special? It works with existing scan data, requiring no additional tests or costs.

March 9, 2026
medical AIfatty liver detectionpreventive healthcare
Chinese AI Cancer Screening Tech Makes Debut in Pakistan
News

Chinese AI Cancer Screening Tech Makes Debut in Pakistan

Alibaba's DAMO Academy has partnered with Pakistani hospitals to introduce AI-powered multi-cancer screening technology. The system, already serving 20 million people globally, helps detect subtle lesions invisible to the human eye. Pakistan's largest cloud provider Sky47 will support the deployment, marking a significant step in bringing advanced medical AI to developing nations.

March 3, 2026
medical AIcancer screeningChina-Pakistan cooperation
News

AI Breakthrough Offers Hope for Rare Disease Diagnosis

Shanghai's Xinhua Hospital has unveiled DeepRare, the world's first traceable AI diagnostic system for rare diseases. Published in Nature, this groundbreaking tool analyzes over 20,000 cases to tackle the notorious challenges of slow and difficult rare disease diagnoses. For families facing these medical mysteries, DeepRare could mean faster answers and better treatment options.

February 28, 2026
medical AIrare diseasesdiagnostic technology
News

iFLYTEK's New Medical AI Outperforms GPT-5.2 in Key Healthcare Tasks

China's iFLYTEK has unveiled its Spark Medical Large Model X2, a specialized AI that surpasses leading models like GPT-5.2 in medical report interpretation and health analysis. This homegrown technology marks significant progress in applying domestic AI to healthcare, transforming from simple consultation tools to comprehensive health management systems. The model has already received certification from Shanghai's medical AI testing center.

February 12, 2026
medical AIiFLYTEKhealthcare technology
Fitbit Founder Returns with AI-Powered Family Health Platform
News

Fitbit Founder Returns with AI-Powered Family Health Platform

James Park, Fitbit's co-founder, is back with a new venture called Luffu. This AI-driven platform aims to solve the messy reality of family healthcare by connecting medical records, daily routines, and communication into one intuitive system. Born from Park's personal caregiving struggles, Luffu promises to ease the mental load for millions managing their family's health.

February 4, 2026
healthtechAIcaregiving
Baichuan's M3 Plus Medical AI Breaks Accuracy Records While Slashing Costs
News

Baichuan's M3 Plus Medical AI Breaks Accuracy Records While Slashing Costs

Baichuan Intelligence has unveiled its upgraded M3 Plus medical AI model just nine days after releasing Baichuan-M3. The new version demonstrates remarkable improvements, reducing hallucination rates by 26% while cutting API costs by 70%. During live tests, M3 Plus outperformed competing medical models with clearer references and more precise answers. These advancements could significantly lower barriers to adoption in healthcare settings.

January 22, 2026
medical AIBaichuan Intelligencehealthcare technology